OBJECTIVE. Our study investigated the usefulness of contrast-enhanced MR imaging for
accurately measuring the size of residual tumor after patients have undergone neoadjuvant …

OBJECTIVE. This study was undertaken to evaluate the ability of MRI to accurately show
residual primary breast malignancy in women treated with neoadjuvant chemotherapy …

AIM: To assess the accuracy of magnetic resonance imaging (MRI) in evaluating residual
disease after neoadjuvant chemotherapy in patients with large breast cancers. MATERIALS …

Background It has been proposed that magnetic resonance imaging (MRI) be used to guide
breast cancer surgery by differentiating residual tumor from pathologic complete response …

Objectives This systematic review aimed to assess the role of magnetic resonance imaging
(MRI) in evaluating residual disease extent and the ability to detect pathologic complete …

Purpose To assess how the molecular biomarker status of a breast cancer, including human
epidermal growth factor receptor 2 (HER2), hormone receptors, and the proliferation marker …

BACKGROUND. This study investigated the role of magnetic resonance imaging (MRI) in
evaluation of pathologically complete response and residual tumors in patients who were …

Purpose: To prospectively document changes in contrast agent kinetics in patients with
primary breast cancer treated with systemic chemotherapy after one or two cycles and to …

The objective of the present study was to monitor response to preoperative chemotherapy
with breast MRI in patients with large breast cancer. Fifty-eight women in whom core biopsy …

Background. This study evaluated the accuracy of magnetic resonance imaging (MRI) for
estimating residual tumor size after neoadjuvant chemotherapy in patients with locally …